formats

Update on Antiphospholipid Antibody – In-Depth Overview for Physicians

Grand Rounds Michael D. Lockshin I want to give you both an overview of the antiphospholipid antibody syndrome and update the audience on things that happened at the recent meeting in Tours, France, which gave some of the most current and up-to-date information on the syndrome. I am also going to give you some speculations

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Update on Antiphospholipid Antibody – In-Depth Overview for Physicians  comments 
formats

When should patients with antiphospholipid antibody be treated with long-term anticoagulation, and how high should the INR be?

Ask the Expert Michael D. Lockshin Currently, the recommendation for asymptomatic patients who have antiphospholipid antibody (regardless of titer) is that they not be treated. One retrospective study, conducted here at HSS, looked at women who had been identified because of fetal loss and were/were not treated with aspirin; the results suggested that aspirin protects

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on When should patients with antiphospholipid antibody be treated with long-term anticoagulation, and how high should the INR be?  comments